Azitra, Inc. cotiza a 0.07 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/…
| Periodo | 2026-05 | 2026-02 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.25 | $-1.17 | $-0.67 | $-1.20 |
| Estimado | $-0.04 | $-0.32 | $-0.77 | $-1.40 |
| Sorpresa | -525.0% | -265.6% | +13.0% | +14.3% |
| Métrica | AZTR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -288.2% | -40.4% | -247.8% |
| ROA | -218.0% | -32.0% | -186.0% |
| Current Ratio | 2.83 | 2.84 | -0.01 |
| Debt / Equity | — | 0.28 | — |